Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clemastine fumarate + dexamethasone vs dexchlorpheniramine maleate in eczema
NCT01257061Phase 3Completed
- Sponsor
- EMS
- Start
- Sep 2012
- Primary completion
- Apr 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of clemastine and dexamethasone in Eczema (2 arms), sponsored by EMS. Primary endpoint: Reduction / improvement of signs and symptoms at 22 days. Started Sep 2012; status: completed.
02
Drugs
clemastinedexamethasone
03
Conditions
Eczema
Beyond the preview
Go deeper on NCT01257061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01257061.